October 19, 2020
Yoshihiro Matsuda, Specialist (Quality), Pharmaceuticals and Medical Devices Agency (Photo taken in January 2018) Three small-molecule drugs are currently approved in Japan with a so-to-say automated production method called “continuous manufacturing,” and while they are all from foreign mega pharma...read more